Overview

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Status:
Recruiting
Trial end date:
2023-11-09
Target enrollment:
Participant gender:
Summary
To see the effect of induction chemotherapy（TPF） followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy (PF) in treating patients with high risk nasopharyngeal carcinoma (NPC).
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University